CardioGenics has developed a portfolio of patent-protected products focused on improving diagnostic testing sensitivity.

Core technology
We have developed a novel, proprietary and patent-protected method for controlling the delivery of compounds to a chemical reaction, thus automating their trigger. The delivery, release and activity of chemical compound in a chemical reaction are controlled by a method that employs an electronic signal. When applied to a chemiluminescent reaction, release of the trigger chemical compound initiates the chemical reaction and thus light generation. The result is a highly sensitive testing platform. This technology is deployed in CardioGenics’ POC platform, allowing a much simplified mechanical design.

Ancillary technologies
A portfolio of patent-protected technologies focused on improving testing sensitivity.

For further information contact us

Stock Info

Information for stock quote is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be delayed.